Amneal Pharmaceuticals, Inc. (AMRX)
11.97
+0.10
(+0.84%)
USD |
NASDAQ |
Dec 09, 16:00
12.02
+0.05
(+0.42%)
After-Hours: 04:44
Amneal Pharmaceuticals Shareholders Equity (Quarterly): -109.46M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -2.642B |
| Johnson & Johnson | 79.28B |
| Amgen, Inc. | 9.619B |
| United Therapeutics Corp. | 6.590B |
| Xeris Biopharma Holdings, Inc. | -0.861M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Total Liabilities (Quarterly) | 3.642B |
| Debt to Equity Ratio | -24.54 |
| Current Ratio | 2.132 |
| Net Debt Paydown Yield | 0.25% |